ACPU
BIIB icon

Arrowgrass Capital Partners (US)’s Biogen BIIB Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-56,916
Closed -$16.9M – 578
2017
Q2 		$15.4M Sell
56,916
-10,520
-16% -$2.78M 0.12% 225
2017
Q1 		$18.4M Buy
67,436
+57,581
+584% +$16.3M 0.19% 154
2016
Q4 		$2.79M Buy
9,855
+6,759
+218% +$2M 0.03% 324
2016
Q3 		$969K Sell
3,096
-44,323
-93% -$13.1M 0.01% 366
2016
Q2 		$11.5M Buy
47,419
+30,594
+182% +$8.06M 0.12% 110
2016
Q1 		$4.38M Buy
+16,825
New +$4.44M 0.05% 203
2015
Q3 		– Sell
-22,500
Closed -$9.09M – 461
2015
Q2 		$9.09M Buy
+22,500
New +$9.03M 0.14% 144

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s BIIB Position: Q3 2017 in Review

Arrowgrass Capital Partners (US) sold out of Biogen (BIIB) in Q3 2017, closing a stake of 56,916 shares — an estimated $16.9M sold.

Arrowgrass Capital Partners (US) first reported a position in BIIB in Q2 2015 and held it in 7 quarters. The position peaked at $18.4M in Q1 2017. 1,015 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

  • Arrowgrass Capital Partners (US) reported no remaining Biogen position as of Q3 2017 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 56,916 Biogen shares in Q3 2017, an estimated $16.9M.
  • Arrowgrass Capital Partners (US) first reported a position in Biogen in Q2 2015 and held it in 7 quarters.
  • Arrowgrass Capital Partners (US)'s Biogen position peaked at $18.4M in Q1 2017.
  • 1,015 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2017, filed 14 Nov 2017.